Difficult decisions: Women of childbearing age, mental illness, and psychopharmacologic therapy

Journal of the American Psychiatric Nurses Association

Volumn 5, Issue 1, 1999, Pages 5-14

  Wintz, Celia Janet Boritz ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0039308936     PISSN: 10783903     EISSN: None     Source Type: Journal    
DOI: 10.1177/107839039900500103     Document Type: Article

References (53)

1. Altshuler, L. L., Cohen, L, Szuba, M. P., Bun, V. K., Gitlin, M., & Mintz, J. (1996). Pharmacologie management of psychiatric illness in pregnancy: Dilemmas and guidelines. American Journal of Psychiatry', 153, 592-606.
2. American Academy of Pediatrics, Committee on Drugs. (1994). The transfer of drugs and other chemicals into human milk. Pediatrics, 93, 137-150.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4. Ananth, J. (1975). Congenital malformations with psychopharmacologic agents. Comprehensive Psychiatry, 16, 437-445.
5. Apfel, R. J., & Handel, M. H. (1993). Madness and loss of motherhood. Washington, DC: American Psychiatric Press.
6. Aruffo, J. G., Coverdale, J. H., Chacko, R. C., & Dworkin, R. J. (1990). Knowledge about AIDS among women psychiatric outpatients. Hospital and Community Psychiatry; 41, 326-328.
7. Beeley, L. (1986). Adverse affects of drugs in later pregnancy. Clinical Obstetrics and Gynecolog); 13, 197-214.
8. Bergman, U., Rosa, F. W., Baum, C., Bengt-Erik, W., & Faich, G. A. (1992). Effect of exposure to benzodiazepine during fetal life. Lancet, 340, 694-696.
9. Buist, A., Norman, T. R., & Dinnerstein , L. (1990). Breastfeeding and the use of psychotropic medication: A review. Journal of Affective Disorders, 19, 197-206.
10. Casiano, M. E., & Hawkins, D. R. (1987). Major mental illness and childbearing. Psychiatric Clinics of North America, 10, 35-51.
11. Cohen, L. S., Friedman, J. M., Jefferson, J. W., Johnson, E. M., & Weiner, M. L. (1994). A réévaluation of risk of in utero exposure to litliium. Journal of the American Medical Association, 271, 146-150.
12. Coverdale, J. H., & Aruffo, J. A. (1989). Family planning needs of female chronic psychiatric outpatients. American Journal of Psychiatry', 146, 1489-1491.
13. Coverdale, J., Aruffo, J., & Grunebaum, H. (1992). Developing family planning services for female chronic mentally ill outpatients. Hospital and Community Psychiatry, 43, 475-478.
14. Elia, J., Katz, I. R., & Simpson, G. R. (1987). Teratogenicity of psychotherapeutic medications. Psycbopharmacology Bulletin, 23, 531-586.
15. Entman, S. S., & Vaughn, W. K. (1984). Lack of relation of oral clefts to diazepine use in pregnancy. New England Journal of Medicine, 310, 1121-1122.
16. Friedman, S., & Harrison, G. (1984). Sexual histories, attitudes, and behavior of schizophrenic and "normal" women. Archives of Sexual Behavior, 13, 555-567.
17. Gerlach, J. (1991). New antipsychotics: Classification, efficacy, and adverse effects. Schizophrenia Bulletin, 17, 289-309.
18. Grunebaum, H. U., Abernethy, V. D., & Rofman, E. S. (1971). The family planning attitudes, practices, and motivations of mental patients. American Journal of Psychiatry, 128, 180-182.
19. Guze, B. H., & Guze, P. A. (1989). Psychotropic medication use during pregnancy. Western Journal of Medicine, 151, 296-298.
20. Jacobson, S. J., Jones, K., & Johnson, K. (1992). Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet, 339, 530-533.
21. Janicak, P. G., Davis, J. M., Preskorn, S. H., & Ayd, F. J., Jr. (1993). Principles and practice of psychopharmacology. Baltimore: Williams & Wilkins.
22. Jones, K. L., Lacro, R. V., Johnson, K. A., £Adams, J. (1989). Pattern of malformations of women treated with carbamazepine during pregnancy. New England Journal of Medicine, 320, 1661-1669.
23. Laegreid, L., Hagberg, G., & Lundberg, A. (1992a). The effect of benzodiazepines on the fetus and newborn. Neuropcdiatrics, 23, 18-23.
24. Laegreid, L., Hagberg, G. & Lundberg, A. (1992b). Neurodevelopment in late infancy after prenatal exposure to benzodiazepines-a prospective study. A'eitropediatrics, 23, 60-67.
25. Leguis, E., Jaeken, J., & Eggermont, E. (1987). Sodium valproate, pregnancy, and infantile fatal liver failure. Lancet, 2, 1518-1519.
26. Marder, S. R., & Van Putten, T. (1995). Antipsychotic medications. In A. F. Schatzberg & C. B. Nemeroff (Eds.), The American Psychiatric Press textbook of psychopharmacology (pp. 247-261). Washington, DC: American Psychiatric Press.
27. Mechanic, D., & Rochefort, D. A. (1992). A policy of inclusion for the mentally ill. Health Affairs, 11, 128-150.
28. Miller, L. J. (199-1). Psychiatric medication during pregnancy: Understanding and minimizing the risks. Psychiatric Annals, 24, 69-75.
29. Miller, L. J. (1998). Pharmacotherapy during the perinatal period. Essential Psychopharmacology, 2, 263-286.
30. Misri, S., & Sivertz, K. (1991)- Tricyclic drugs in pregnancy and lactation: A preliminary report. International Journal of Psychiatry in Medicine, 21, 157-171.
31. Mortola, J. F. (1989). The use of psychotropic agents in pregnancy and lactation. Psychiatric Clinics of North America, 12, 69-87.
32. National Institute of Mental Health. (1986). Client/patient sample survey of inpatient, outpatient, and partial care programs. Rockville, MD: U.S. Department of Health and Human Services, NIMH Survey and Reports Branch, Division of Biometry.
33. National Institute of Mental Health. (1987). Toward a model plan for a comprehensive community based mental health system. Rockville, MD: U.S. Department of Health and Human Services, Alcohol, Drug Abuse, and Mental Health Administration.
34. Nora, J. J., Nora, A. H., & Way, G. I. (1975). Cardiovascular maldevelopment associated with maternal exposure to amantadine. Lancet, 2, 607.
35. Nulman, I., Rovet, J., Stewart, D. E., \Volpin, J., Gardner, H. A., Theis, J. G., Kulin, N., & Koren, G. (1997). Neurcxlevelopment of children exposed in utero to antidepressant drugs. New England Journal of Medicine, 336, 258-336.
36. Nürnberg, H. G., & Prudic, J. (1984). Guidelines for treatment of psychosis during pregnancy. Hospital and Community Psychiatry, 35, 67-71.
37. Packer, S. (1992). Family planning for women with bipolar disorder. Hospital and Community Psychiatry, 43, 479-482.
38. Robinson, G. E., Stewart, D. E., & Flak, E. (1986). The rational use of psychotropic drugs in pregnancy and postpartum. Canadian Journal of Psychiatry, 31, 183-190.
39. Rudolph, B., Larson, G. L, Sweeny, S., Hough, E. E., & Arorian, K. (1990). Hospitalized pregnant psychotic women: Characteristics and treatment issues. Hospital and Community Psychiatry, 41, 159-163.
40. Sachs, M. H., Perry, S., Graver, R., Shindledecker, R., & Hall, S. (1990). Self-reported HIV-related risk behaviors in acute psychiatric inpatients: A pilot study. Hospital and Community Psychiatry, 41, 1253-1255.
41. Scolnik, D., Nulman, I., Rovet, J.,Gladstone, D., Czuchta, D., Gardner, H. A., Gladstone, R., Ashby, P., Weksberg, R., Einarson, T., & Koren, G. (1994). Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. journal of the American Medical Association, 271, 767-770.
42. Schou, M. (1968). Special review: Lithium in psychiatric therapy and prophylaxis. Journal of Psychiatric Research, 6, 67-95.
43. Schou, M. (1976). What happened to the lithium babies: A followup of children without malformations. Acta Psychiatrien Scandinavica, 54, 193-197.
44. Schou, M. (1990). Lithium treatment during pregnancy, delivery and lactation: An update. Journal of Clinical Psychiatry, 51, 410-413.
45. Spielvogel, A., & Wile, J. (1992). Treatment and outcomes of psychotic patients during pregnancy and childbirth. Birth, 19, 131-137.
46. St. Clair, S. M., & Schirmer, R. G. (1992). First-trimester exposure to alprazolam. Obstetrics and Gynecology, 80, 843-846.
47. Stowe, Z. N., & Nemeroff, C. B. (1995). Psychopharmacology during pregnancy and lactation. In A. F. Schatzberg & C. B. Nermeroff (Eds.), The American Psychiatric Press textbook of psychopharmacology (pp. 823-838). Washington, DC: American Psychiatric Press.
48. Test, M. A., & Berlin, S. B. (1981). Issues of special concern to chronically mentally ill women. Professional Psychology, 12, 136-145.
49. Verhulst, J., & Schneidman, B. (1981). Schizophrenia and sexual functioning. Hospital and Community Psychiatry, 32, 259-262.
50. Vorhees, C. V., Minck, D. R., & Berry, H. K. (1988). Anticonvulsants and brain development. Progress in Brain Research, 73, 229-244.
51. Winter, R. M., Donnai, D., Burn, J., & Tucker, S. M. (1987). Fetal valproate syndrome: Is there a recognisable phenotype? Journal of Medical Genetics, 24, 692-695.
52. Wisner, K. L, & Perel, J. M. (1988). Psychopharmacologic agents and electroconvulsive therapy during pregnancy and the puerperium. In R. L. Cohen (Ed.), Psychiatric consultation in childbirth settings: Parent and child oriented approaches (pp. 165-206). New York: Plenum Medical Book Co.
53. Wright, S., Dawling, S., & Ashford, J. J. (1991). Execretion of fluvoxamine in breast milk. British Journal of Clinical Pharmacology, 31, 209.